AMP:MILAmplifon SpA Analysis

Amplifon trades at €10.79, notably below its DCF fair value of €12.93, implying roughly a 16.7% upside. The stock benefits from a bullish MACD histogram, a neutral‑to‑slightly‑overbought RSI at 59, and an increasing volume trend, while staying comfortably above the identified support of €9.20. However, the company faces a steep debt load (debt‑to‑equity ≈ 167) and modest profitability (ROE ≈ 6.2%, profit margin ≈ 2.9%), with revenue contracting 1.4% YoY.
The dividend yield of 2.65% is attractive but the payout ratio hovers near 95%, raising sustainability concerns. Valuation metrics—forward PE ≈ 11.4 versus an industry average of 26.9—suggest a value‑oriented case, and demographic trends in hearing health provide a long‑run tailwind despite current earnings pressure.